|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
AMD Market Outlook to 2012
AMD is the most common cause of vision loss in the developed world for those over 50 years of age. We estimate there are over 20 million cases in the US and Europe.
Non-hormonal Treatments for Menopausal Symptoms
This report provides analysis of the commercial and clinical potential of non-hormonal treatments for menopausal symptoms based on seven key opinion leader interviews, with focus on the treatment of vasomotor symptoms.
Women’s Health - Infertility Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of infertility drugs by company and by stage as well as a summary of the latest news and developments in this area.
Dental - Dental - Pain Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of dental pain drugs by company and by stage as well as a summary of the latest news and developments in this area.
Pipeline and Commercial Insight: Urinary Incontinence
The UI market is set to continue to grow over the next 6 years, reaching over $2.5 billion in 2012, a 68% increase from 2006. Lifecycle management strategies, novel formulations and follow-on products will drive the majority of this growth, with key b
Dental - Caries Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of caries drugs by company and by stage as well as a summary of the latest news and developments in this area.
Stress Urinary Incontinence - Opinion Divided on Drug Therapy
Stress urinary incontinence (SUI) is the most common type of urinary incontinence in women. Up until recently there were no globally developed or widely approved pharmacological treatments for this disorder leaving women with few treatment optionsnon-
Interstitial Cystitis - Few Treatments, Poor Outcome
Interstitial cystitis (IC) is considered a rare disorder and poor understanding of the underlying causes of the disorder have made diagnosis and management difficult. Moreover, this has impacted on the development of effective drugs for this disordert
Dry Overactive Bladder - A Precursor to Wet Overactive Bladder?
Dry Overactive Bladder (dry OAB) is considered part of the overactive bladder syndrome. However, unlike wet overactive bladder (or urge urinary incontinence), it is normally only associated with urinary urgency and frequency, and not incontinence. Eve
Urge Urinary Incontinence - Poor Differentiation...
Urge urinary incontinence (UUI) is a relatively common disorder which can affect all age groups but becomes increasingly prevalent with old age. Although several pharmacological therapies are available for treating this distressing condition, patients
Management of Urinary Incontinence and Overactive Bladder
Although there are many marketed treatments for overactive bladder, there are few available for stress urinary incontinence or interstitial cystitis. Furthermore, despite available treatments for overactive bladder, many are associated with side effec
Results 1 - 25 of 25
|
|
|
|
|
|
